Search by Drug Name or NDC
NDC 62135-0937-54 Cholestyramine for Oral Suspension 4 g/5.7g Details
Cholestyramine for Oral Suspension 4 g/5.7g
Cholestyramine for Oral Suspension is a ORAL POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is CHOLESTYRAMINE.
Product Information
| NDC | 62135-0937 |
|---|---|
| Product ID | 62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615 |
| Associated GPIs | |
| GCN Sequence Number | 062885 |
| GCN Sequence Number Description | cholestyramine/aspartame POWDER 4 G ORAL |
| HIC3 | D7L |
| HIC3 Description | BILE SALT SEQUESTRANTS |
| GCN | 98654 |
| HICL Sequence Number | 001373 |
| HICL Sequence Number Description | CHOLESTYRAMINE/ASPARTAME |
| Brand/Generic | Generic |
| Proprietary Name | Cholestyramine for Oral Suspension |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cholestyramine for Oral Suspension |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | g/5.7g |
| Substance Name | CHOLESTYRAMINE |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074562 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0937-54 (62135093754)
| NDC Package Code | 62135-937-54 |
|---|---|
| Billing NDC | 62135093754 |
| Package | 239.4 g in 1 CAN (62135-937-54) |
| Marketing Start Date | 2023-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.18299 |
| Pricing Unit | GM |
| Effective Date | 2023-11-22 |
| NDC Description | CHOLESTYRAMINE LIGHT POWDER |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis